Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

Stopped early · Phase 2

Conditions studied: Obsessive Compulsive Disorder

In brief

The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.

Key facts

Study ID

NCT00515255

Run by

Neuropharm

People needed

6

Starts

2007-07-01

Expected to finish

2008-04-01

Last updated by the study team

2012-04-27

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets DSM-IV criteria for Obsessive Compulsive Disorder.
• CY-BOCS score of greater or equal to 16 at screening.
• NIMH Global OC Scale score of 7 or higher at screening.

You may not qualify if…

• Patients planning to commence cognitive behaviour therapy during the period of the study or those who have begun cognitive behaviour therapy within 8 weeks prior to enrolment.
• Autistic Disorder or Pervasive Developmental Disorder.
• Moderate or severe mental retardation.
• Severe renal insufficiency.
• Other protocol-defined Inclusion/Exclusion criteria may apply.

Where it is running

• New York State Psychiatric Institute, Columbia University — New York, New York, United States
• University Hospitals Case Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.